A detailed history of Fora Capital, LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 4,599 shares of JANX stock, worth $235,008. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,599
Previous 4,858 5.33%
Holding current value
$235,008
Previous $203,000 2.46%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$35.29 - $50.26 $9,140 - $13,017
-259 Reduced 5.33%
4,599 $208,000
Q2 2024

Aug 13, 2024

BUY
$35.12 - $64.78 $170,612 - $314,701
4,858 New
4,858 $203,000

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.13B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.